Results 201 to 210 of about 17,787 (263)

Dermatologic Therapy With Immunosuppressive Agents

Postgraduate Medicine, 1975
The use of powerful immunosuppressive agents such as methotrexate, cyclophosphamide, and azathioprine in the treatment of serious skin diseases is a relatively recent development whose efficacy is borne out in many studies. Using an immunosuppressant often makes possible an appreciable reduction in dosage of steroid necessary to control disease and, in
James J Leyden
exaly   +3 more sources

DERMATOLOGIC SIDE EFFECTS OF PSYCHOPHARMACOLOGIC AGENTS

Dermatologic Clinics, 1996
Exanthematous eruptions, urticaria, photosensitivity, pigmentary problems, acne, alopecia, fixed drug eruptions, and lichenoid reactions are the most common dermatologic side effects associated with the administration of psychopharmacologic agents. The cutaneous findings associated with the various eruptions and the most common inciting psychiatric ...
exaly   +3 more sources

Immunosuppressive Agents in Dermatology

Dermatologic Clinics, 1993
Azathioprine, cyclophosphamide, and cyclosporine are immunosuppressive agents commonly used by dermatologists. Azathioprine has a good safety profile and is preferred by most dermatologists for the treatment of bullous pemphigoid, cutaneous vasculitides, chronic eczematous dermatitides, and cutaneous manifestations of connective tissue diseases.
V C, Ho, D M, Zloty
openaire   +2 more sources

Antifungal agents in dermatology

Journal of the American Academy of Dermatology, 1987
Development of new antifungal agents has increased significantly over the past two decades, with recent advances reflecting interest in synthetic agents as opposed to antibiotics. We review the various antifungal medications in use or under development, beginning with a discussion of over-the-counter agents, antibiotics, and older azole compounds and ...
J L, Lesher, J G, Smith
openaire   +2 more sources

Topical Antibacterial Agents in Dermatology

The Journal of Dermatology, 2003
AbstractTopical antibacterials are being widely used for the treatment or prevention of superficial bacterial infections. Emergence of drug resistant mutant strains of microorganisms and development of irritant and allergic contact dermatitis is a common problem with many of the topical antibacterials.
Anjum, Singal, Gurvinder P, Thami
openaire   +2 more sources

Dermatologic Toxicity of Chemotherapeutic Agents

Seminars in Oncology, 2006
Due to its high metabolic rate, skin represents one of the major target organs of chemotherapy-associated toxicity. Reactions range from common, nonspecific exanthematous eruptions to rare but distinctive cutaneous lesions that may not become apparent until a drug transitions from clinical trials to widespread oncologic use.
Aimee S, Payne, William D, James, Raymond B, Weiss   +2 more
openaire   +2 more sources

Allergy to Dermatologic Agents

JAMA: The Journal of the American Medical Association, 1966
Between 1962 and 1965, 78 cases of allergy to topically administered medicaments were documented in the author's private practice. In 60 of the 78 patients the allergy had been responsible for causing or aggravating a dermatitis. Antimicrobials, antihistamines, and anesthetics were the most prominent allergens with neomycin being the single most ...
openaire   +2 more sources